Investor Relations & Capital Introduction in Mainz

Mainz is the capital of Rhineland-Palatinate, across the Rhine from Wiesbaden and close to Frankfurt. For founders, it offers a world-famous biotechnology company, strong university research and media and wine industries.

Why Mainz Matters for Capital Raising

BioNTech, the company behind one of the first approved COVID-19 vaccines, was founded in Mainz in 2008.

Johannes Gutenberg developed movable-type printing in Mainz in the 15th century, and the city's university bears his name.

Mainz is a centre for German broadcasting and the Rheinhessen wine region.

What Mainz Investors Examine

For biotech companies, clinical data and regulatory pathways are examined closely.

Investors value strong science and experienced management.

Engagement and Access

GCN connects founders with Mainz investors and the wider Frankfurt investor community through conference programming and private sessions.

Sectors where we see consistent Mainz interest include biotechnology and life sciences, media and broadcasting, wine and food, and public sector technology.

Partner with Global Capital Network

Whether you are raising into Mainz or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.